NVR vs PLX · P/E 15, rev $4.21B vs P/E 31, rev $53.6M
NVR Inc (NVR) versus Protalix Biotherapeutics Inc (PLX) — a side-by-side from cached financials, not a winner call.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Latest reported PLX revenue for 2026-06-30 was $53.6M. Net income was $22.1M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
NVR currently screens at market cap $16.94B and trailing P/E 15.3. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Not investment advice. Open the NVR and PLX stock pages for the full models.
Not investment advice.